Literature DB >> 25293425

Association of blood products administration during cardiopulmonary bypass and excessive post-operative bleeding in pediatric cardiac surgery.

Hemant S Agarwal1, Sarah S Barrett, Kristen Barry, Meng Xu, Benjamin R Saville, Brian S Donahue, Zena L Harris, David P Bichell.   

Abstract

Our objectives were to study risk factors and post-operative outcomes associated with excessive post-operative bleeding in pediatric cardiac surgeries performed using cardiopulmonary bypass (CPB) support. A retrospective observational study was undertaken, and all consecutive pediatric heart surgeries over 1 year period were studied. Excessive post-operative bleeding was defined as 10 ml/kg/h of chest tube output for 1 h or 5 ml/kg/h for three consecutive hours in the first 12 h of pediatric cardiac intensive care unit (PCICU) stay. Risk factors including demographics, complexity of cardiac defect, CPB parameters, hematological studies, and post-operative morbidity and mortality were evaluated for excessive bleeding. 253 patients were studied, and 107 (42 %) met the criteria for excessive bleeding. Bayesian model averaging revealed that greater volume of blood products transfusion during CPB was significantly associated with excessive bleeding. Multiple logistic regression analysis of blood products transfusion revealed that increased volume of packed red blood cells (PRBCs) administration for CPB prime and during CPB was significantly associated with excessive bleeding (p = 0.028 and p = 0.0012, respectively). Proportional odds logistic regression revealed that excessive bleeding was associated with greater time to achieve negative fluid balance, prolonged mechanical ventilation, and duration of PCICU stay (p < 0.001) after adjusting for multiple parameters. A greater volume of blood products administration, especially PRBCs transfusion for CPB prime, and during the CPB period is associated with excessive post-operative bleeding. Excessive bleeding is associated with worse post-operative outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 25293425     DOI: 10.1007/s00246-014-1034-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  31 in total

Review 1.  The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist.

Authors:  John G Laffey; John F Boylan; Davy C H Cheng
Journal:  Anesthesiology       Date:  2002-07       Impact factor: 7.892

2.  Risk adjustment for congenital heart surgery: the RACHS-1 method.

Authors:  Kathy J Jenkins
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2004

3.  The risk associated with aprotinin in cardiac surgery.

Authors:  Dennis T Mangano; Iulia C Tudor; Cynthia Dietzel
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

4.  Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

Authors:  Kathryn A O'Connell; Jennifer J Wood; Robert P Wise; Jay N Lozier; M Miles Braun
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

Review 5.  Thrombin during cardiopulmonary bypass.

Authors:  L Henry Edmunds; Robert W Colman
Journal:  Ann Thorac Surg       Date:  2006-12       Impact factor: 4.330

6.  Transfusion-induced leukocyte IL-8 gene expression is avoided by the use of human polymerized hemoglobin.

Authors:  Forest R Sheppard; Ernest E Moore; Jeffrey L Johnson; Aaron M Cheng; Nathan McLaughlin; Christopher C Silliman
Journal:  J Trauma       Date:  2004-10

Review 7.  Mediastinal bleeding after cardiopulmonary bypass in pediatric patients.

Authors:  J Guay; G E Rivard
Journal:  Ann Thorac Surg       Date:  1996-12       Impact factor: 4.330

8.  Bleeding and use of blood products after heart operations in infants.

Authors:  J Petäjä; U Lundström; M Leijala; K Peltola; M A Siimes
Journal:  J Thorac Cardiovasc Surg       Date:  1995-03       Impact factor: 5.209

9.  Increased red blood cell transfusions are associated with worsening outcomes in pediatric heart transplant patients.

Authors:  Kimberly Howard-Quijano; Johanna C Schwarzenberger; Jennifer C Scovotti; Alexandra Alejos; Jason Ngo; Jeffrey Gornbein; Aman Mahajan
Journal:  Anesth Analg       Date:  2013-04-04       Impact factor: 5.108

10.  Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.

Authors:  Michael J Eisses; Wayne L Chandler
Journal:  J Cardiothorac Vasc Anesth       Date:  2007-08-22       Impact factor: 2.628

View more
  9 in total

1.  Plasma and Platelet Transfusions Strategies in Neonates and Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass or Neonates and Children Supported by Extracorporeal Membrane Oxygenation: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.

Authors:  Jill M Cholette; Jennifer A Muszynski; Juan C Ibla; Sitaram Emani; Marie E Steiner; Adam M Vogel; Robert I Parker; Marianne E Nellis; Melania M Bembea
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.971

Review 2.  Mechanical blood trauma in assisted circulation: sublethal RBC damage preceding hemolysis.

Authors:  Salim E Olia; Timothy M Maul; James F Antaki; Marina V Kameneva
Journal:  Int J Artif Organs       Date:  2016-03-30       Impact factor: 1.595

3.  Recommendations on RBC Transfusions in Critically Ill Children With Acute Respiratory Failure From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Pierre Demaret; Guillaume Emeriaud; Nabil E Hassan; Martin C J Kneyber; Stacey L Valentine; Scot T Bateman; Marisa Tucci
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

4.  Recommendations on RBC Transfusion in Infants and Children With Acquired and Congenital Heart Disease From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Jill M Cholette; Ariane Willems; Stacey L Valentine; Scot T Bateman; Steven M Schwartz
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

5.  Effect of 22q11.2 deletion on bleeding and transfusion utilization in children with congenital heart disease undergoing cardiac surgery.

Authors:  Michelle K Brenner; Shanelle Clarke; Donna K Mahnke; Pippa Simpson; Rachel S Bercovitz; Aoy Tomita-Mitchell; Michael E Mitchell; Debra K Newman
Journal:  Pediatr Res       Date:  2015-10-22       Impact factor: 3.756

6.  Audit of transfusion of blood products in paediatric congenital heart surgery on cardiopulmonary bypass.

Authors:  Caroline Tumelo Bayebaye; Michel Kasongo Muteba; Palesa Motshabi Chakane
Journal:  Cardiovasc J Afr       Date:  2018-11-06       Impact factor: 0.802

Review 7.  Strategies for blood conservation in pediatric cardiac surgery.

Authors:  Sarvesh Pal Singh
Journal:  Ann Card Anaesth       Date:  2016 Oct-Dec

Review 8.  Bleeding in Critically Ill Children-Review of Literature, Knowledge Gaps, and Suggestions for Future Investigation.

Authors:  Adi Avniel Aran; Oliver Karam; Marianne E Nellis
Journal:  Front Pediatr       Date:  2021-01-27       Impact factor: 3.418

9.  Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.

Authors:  J A Peterson; S A Maroney; W Zwifelhofer; J P Wood; K Yan; R S Bercovitz; R K Woods; A E Mast
Journal:  J Thromb Haemost       Date:  2018-08-16       Impact factor: 5.824

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.